The DOI matches its Crossref record; 35 of the 36 references it cites were found in a registry or an index.
A Phase 2 Study of Chronocort, a Modified-Release Formulation of Hydrocortisone, in the Treatment of Adults With Classic Congenital Adrenal Hyperplasia
Open accessAbstract
CONTEXT: Treatment of congenital adrenal hyperplasia (CAH) is suboptimal. Inadequate suppression of androgens and glucocorticoid excess are common and current glucocorticoid formulations cannot replace the cortisol circadian rhythm. OBJECTIVES: The primary objective was to characterize the pharmacokinetic profile of Chronocort, a modified-release hydrocortisone formulation, in adults with CAH. Secondary objectives included examining disease control following 6 months of Chronocort with dose titration. DESIGN, SETTING, AND PATIENTS: Sixteen adults (eight females) with classic CAH participated in an open-label, nonrandomized, Phase 2 study at the National Institutes of Health Clinical Center. Twenty-four-hour blood sampling was performed on conventional glucocorticoids and following 6 months of Chronocort. Chronocort was initiated at 10 mg (0700 h) and 20 mg (2300 h). Dose titration was performed based on androstenedione and 17-hydroxyprogresterone (17-OHP) levels and clinical symptomatology. MAIN OUTCOME MEASURES: The primary outcome was cortisol pharmacokinetics of Chronocort and secondary outcomes included biomarkers of CAH control (androstenedione and 17-OHP). RESULTS: In patients with CAH, Chronocort cortisol profiles were similar to physiologic cortisol secretion. Compared with conventional therapy, 6 months of Chronocort resulted in a decrease in hydrocortisone dose equivalent (28 ± 11.8 vs 25.9 ± 7.1 mg/d), with lower 24-hour (P = .004), morning (0700-1500 h; P = .002), and afternoon (1500-2300 h; P = .011) androstenedione area under the curve (AUC) and lower 24-hour (P = .023) and morning (0700-1500 h; P = .02) 17-OHP AUC. CONCLUSIONS: Twice-daily Chronocort approximates physiologic cortisol secretion, and was well tolerated and effective in controlling androgen excess in adults with CAH. This novel hydrocortisone formulation represents a new treatment approach for patients with CAH.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Both the once-daily (56) and twice-daily (57) modified-released versions have been shown to be a closer mimic of the physiological circadian rhythm, compared to the conventional multiple-dose regimen.”
From Hypoglycaemia in adrenal insufficiency (2023) · cites this paper as [57]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Infants prenatally exposed to betamethasone have altered responses of the HPA axis and a higher incidence of mental and behavioral disorders (490,491).”
From Congenital Adrenal Hyperplasia—Current Insights in Pathophysiology, Diagnostics, and Management (2022) · cites this paper as [490]
Experimental — accuracy not yet measuredIn the citing paper
“Continuous subcutaneous hydrocortisone infusion via an insulin pump mimicking cortisol circadian rhythm, has similarly shown adequate ACTH suppression with lower total hydrocortisone dose compared to conventional treatment, 139-142”
From Congenital adrenal hyperplasia (2017) · cites this paper as [140]
In the citing paper
“A modified-release oral hydrocortisone preparation, Chronocort ® , was successful in achieving lower androgen levels while decreasing the hydrocortisone equivalent dose using a twice-daily regimen in a Phase 2 study of 16 patients with classic 21OH deficiency.140”
From Congenital adrenal hyperplasia (2017) · cites this paper as [140]
In the citing paper
“Chronocort capsules demonstrated control of adrenal androgens throughout the day despite down-titration, with no serious adverse events109.”
From Management challenges and therapeutic advances in congenital adrenal hyperplasia (2022) · cites this paper as [109]
In the citing paper
“Compared with various forms of conventional therapy prior to entry, this approach yielded decreased 17OHP and androstenedione values throughout the day, despite a reduced HC dose equivalent (28 6 11.8 vs 25.9 6 7.1 mg/d).”
From Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society* Clinical Practice Guideline (2018) · cites this paper as [312]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Speiser, P. W., Azziz, R., Baskin, L. S., Ghizzoni, L., Hensle, T. W., Merke, D. P., Meyer-Bahlburg, H. F. L., Miller, W. L., Montori, V. M., Oberfield, S. E., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2631 · Cited by 1,468 · cited 1×
“recommended therapy in growing children (2).”
Self-citationBuckley, T. M., & Schatzberg, A. F. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1056 · Cited by 964
Congenital adrenal hyperplasia
El-Maouche, D., Arlt, W., & Merke, D. P. (2017) · The Lancet · doi:10.1016/s0140-6736(17)31431-9 · Cited by 669
Self-citationHealth status of adults with congenital adrenal hyperplasia: a cohort study of 203 patients
Arlt, W., Willis, D. S., Wild, S. H., Krone, N., Doherty, E. J., Hahner, S., Han, T. S., Carroll, P. V., Conway, G. S., Rees, D. A., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0917 · Cited by 506
Self-citationComparison of self-reported fatigue in rheumatoid arthritis and controls.
Bl, B. (1995) · PubMed · Cited by 355
Johannsson, G., Nilsson, A. G., Bergthorsdottir, R., Burman, P., Dahlqvist, P., Ekman, B., Engström, B. E., Olsson, T., Ragnarsson, O., Ryberg, M., et al. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-1926 · Cited by 329
Modified-release hydrocortisone to provide circadian cortisol profiles
Debono, M., Ghobadi, C., Rostami-Hodjegan, A., Huatan, H., Campbell, M. J., Newell-Price, J., Darzy, K., Merke, D. P., Arlt, W., & Ross, R. J. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-2380 · Cited by 322
Self-citationClinical characteristics of a cohort of 244 patients with congenital adrenal hyperplasia
Finkielstain, G. P., Kim, M. S., Sinaii, N., Nishitani, M., Van Ryzin, C., Hill, S. C., Reynolds, J. C., Hanna, R. M., & Merke, D. P. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-2102 · Cited by 313
Self-citationMah, P. M., Jenkins, R. C., Rostami‐Hodjegan, A., Newell‐Price, J., Doane, A., Ibbotson, V., Tucker, G. T., & Ross, R. J. (2004) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2004.02106.x · Cited by 243
Self-citationGlucocorticoid-induced osteoporosis: mechanisms, management, and future perspectives
Seibel, M. J., Cooper, M. S., & Zhou, H. (2013) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(13)70045-7 · Cited by 235
Cited by
Sorted by citations
Bornstein, S. R., Allolio, B., Arlt, W., Barthel, A., Don-Wauchope, A., Hammer, G. D., Husebye, E. S., Merke, D. P., Murad, M. H., Stratakis, C. A., et al. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-1710 · Cited by 1,769
Self-citationSpeiser, P. W., Arlt, W., Auchus, R. J., Baskin, L. S., Conway, G. S., Merke, D. P., Meyer-Bahlburg, H. F. L., Miller, W. L., Murad, M. H., Oberfield, S. E., et al. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-01865 · Cited by 1,234
Self-citationRussell, G., & Lightman, S. (2019) · Nature Reviews Endocrinology · doi:10.1038/s41574-019-0228-0 · Cited by 1,032
Congenital adrenal hyperplasia
El-Maouche, D., Arlt, W., & Merke, D. P. (2017) · The Lancet · doi:10.1016/s0140-6736(17)31431-9 · Cited by 669
Self-citationCongenital Adrenal Hyperplasia—Current Insights in Pathophysiology, Diagnostics, and Management
Claahsen - van der Grinten, H. L., Speiser, P. W., Ahmed, S. F., Arlt, W., Auchus, R. J., Falhammar, H., Flück, C. E., Guasti, L., Huebner, A., Kortmann, B. B. M., et al. (2022) · Endocrine Reviews · doi:10.1210/endrev/bnab016 · Cited by 556
Self-citationThe Functional and Clinical Significance of the 24-Hour Rhythm of Circulating Glucocorticoids
Oster, H., Challet, E., Ott, V., Arvat, E., de Kloet, E. R., Dijk, D.-J., Lightman, S., Vgontzas, A., & Van Cauter, E. (2017) · Endocrine Reviews · doi:10.1210/er.2015-1080 · Cited by 548
Congenital adrenal hyperplasia due to 21-hydroxylase deficiency
Merke, D. P., & Auchus, R. J. (2020) · New England Journal of Medicine · doi:10.1056/nejmra1909786 · Cited by 341
Self-citationDosing-Time Makes the Poison: Circadian Regulation and Pharmacotherapy
Dallmann, R., Okyar, A., & Lévi, F. (2016) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2016.03.004 · Cited by 298
Hahner, S., Ross, R. J., Arlt, W., Bancos, I., Burger-Stritt, S., Torpy, D. J., Husebye, E. S., & Quinkler, M. (2021) · Nature Reviews Disease Primers · doi:10.1038/s41572-021-00252-7 · Cited by 223
Self-citationTreating the Side Effects of Exogenous Glucocorticoids; Can We Separate the Good From the Bad ?
Pofi, R., Caratti, G., Ray, D. W., & Tomlinson, J. (2023) · Endocrine Reviews · doi:10.1210/endrev/bnad016 · Cited by 237
Carmina, E., Dewailly, D., Escobar-Morreale, H. F., Keleştimur, F., Morán, C., Oberfield, S. E., Witchel, S. F., & Azziz, R. (2017) · Human Reproduction Update · doi:10.1093/humupd/dmx014 · Cited by 206
Congenital Adrenal Hyperplasia
Witchel, S. F. (2017) · Journal of Pediatric and Adolescent Gynecology · doi:10.1016/j.jpag.2017.04.001 · Cited by 187
Nordenström, A., & Falhammar, H. (2019) · European Journal of Endocrinology · doi:10.1530/eje-18-0712 · Cited by 158
Tamhane, S., Rodriguez-Gutierrez, R., Iqbal, A. M., Prokop, L. J., Bancos, I., Speiser, P. W., & Murad, M. H. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-01862 · Cited by 123
Adrenal insufficiency – recognition and management
Pazderska, A., & Pearce, S. H. S. (2017) · Clinical Medicine · doi:10.7861/clinmedicine.17-3-258 · Cited by 123
Management challenges and therapeutic advances in congenital adrenal hyperplasia
Mallappa, A., & Merke, D. P. (2022) · Nature Reviews Endocrinology · doi:10.1038/s41574-022-00655-w · Cited by 113
Self-citationBancos, I., Hazeldine, J., Chortis, V., Hampson, P., Taylor, A. E., Lord, J. M., & Arlt, W. (2017) · European Journal of Endocrinology · doi:10.1530/eje-16-0969 · Cited by 110
Self-citationAn Update on Addison’s Disease
Barthel, A., Benker, G., Berens, K., Diederich, S., Manfras, B. J., Grüber, M., Kanczkowski, W., Kline, G. A., Kamvissi, V., Hahner, S., et al. (2018) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-0804-2715 · Cited by 115
Modified-Release Hydrocortisone in Congenital Adrenal Hyperplasia
Merke, D. P., Mallappa, A., Arlt, W., Brac de la Perriere, A., Lindén Hirschberg, A., Juul, A., Newell-Price, J., Perry, C. G., Prete, A., Rees, D. A., et al. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab051 · Cited by 109
Self-citationEl-Maouche, D., Hargreaves, C. J., Sinaii, N., Mallappa, A., Veeraraghavan, P., & Merke, D. P. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-00208 · Cited by 93
Self-citationNella, A. A., Mallappa, A., Perritt, A. F., Gounden, V., Kumar, P., Sinaii, N., Daley, L.-A., Ling, A., Liu, C.-Y., Soldin, S. J., et al. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-1916 · Cited by 91
Self-citationWhittle, E., & Falhammar, H. (2019) · Journal of the Endocrine Society · doi:10.1210/js.2019-00136 · Cited by 87
Electrostatic powder coating: Principles and pharmaceutical applications
Prasad, L. K., McGinity, J. W., & Williams, R. O. (2016) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2016.04.016 · Cited by 82
Monogenic disorders of adrenal steroidogenesis
Baranowski, E. S., Arlt, W., & Idkowiak, J. (2018) · Hormone Research in Paediatrics · doi:10.1159/000488034 · Cited by 79
Self-citationPrimary adrenal insufficiency in children: Diagnosis and management
Kırkgöz, T., & Güran, T. (2018) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2018.05.010 · Cited by 82
Human studies on hypothalamo-pituitary-adrenal (HPA) axis
Liyanarachchi, K., Ross, R. J. M., & Debono, M. (2017) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2017.10.011 · Cited by 83
Self-citationJones, C. M., Mallappa, A., Reisch, N., Nikolaou, N., Krone, N., Hughes, B. A., O’Neil, D. M., Whitaker, M. J., Tomlinson, J. W., Storbeck, K.-H., et al. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-2855 · Cited by 74
Self-citationThe next 150 years of congenital adrenal hyperplasia
Turcu, A. F., & Auchus, R. J. (2015) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2015.05.013 · Cited by 69
Abiraterone acetate treatment lowers 11-oxygenated androgens
Wright, C., O’Day, P., Alyamani, M., Sharifi, N., & Auchus, R. J. (2020) · European Journal of Endocrinology · doi:10.1530/eje-19-0905 · Cited by 68
Turcu, A. F., Spencer-Segal, J. L., Farber, R. H., Luo, R., Grigoriadis, D. E., Ramm, C. A., Madrigal, D., Muth, T., O'Brien, C. F., & Auchus, R. J. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-3574 · Cited by 61
Disorders of Sex Development of Adrenal Origin
Finkielstain, G. P., Vieites, A., Bergadá, I., & Rey, R. A. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.770782 · Cited by 60
Pediatric Adrenal Insufficiency: Diagnosis, Management, and New Therapies
Bowden, S. A., & Henry, R. K. (2018) · International Journal of Pediatrics · doi:10.1155/2018/1739831 · Cited by 62
Webb, E. A., & Krone, N. P. (2015) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2015.04.002 · Cited by 59
Auchus, R. J., Sarafoglou, K., Fechner, P. Y., Vogiatzi, M. G., Imel, E. A., Davis, S. M., Giri, N., Sturgeon, J., Roberts, E., Chan, J. L., et al. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab749 · Cited by 55
Bachelot, A., Grouthier, V., Courtillot, C., Dulon, J., & Touraine, P. A. (2017) · European Journal of Endocrinology · doi:10.1530/eje-16-0888 · Cited by 57
Novel insights into glucocorticoid replacement therapy for pediatric and adult adrenal insufficiency
Oprea, A., Bonnet, N., Pollé, O. G., & Lysy, P. A. (2019) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/2042018818821294 · Cited by 59
Paizoni, L., Auer, M. K., Schmidt, H., Hübner, A., Bidlingmaier, M., & Reisch, N. (2020) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2019.105540 · Cited by 53
Is physiological glucocorticoid replacement important in children?
Porter, J., Blair, J., & Ross, R. J. (2017) · Archives of Disease in Childhood · doi:10.1136/archdischild-2015-309538 · Cited by 50
Self-citationMiller, B. S., Spencer, S. P., Geffner, M. E., Gourgari, E., Lahoti, A., Kamboj, M. K., Stanley, T. L., Uli, N. K., Wicklow, B. A., & Sarafoglou, K. (2019) · Journal of Investigative Medicine · doi:10.1136/jim-2019-000999 · Cited by 51
Glucocorticoid replacement regimens for treating congenital adrenal hyperplasia
Ng, S. M., Stępień, K. M., & Krishan, A. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012517.pub2 · Cited by 51
Clinical advances in the pharmacotherapy of congenital adrenal hyperplasia
Prete, A., Auchus, R. J., & Ross, R. J. (2022) · White Rose Research Online (University of Leeds, The University of Sheffield, University of York) · Cited by 46
Self-citationMallappa, A., Nella, A. A., Sinaii, N., Rao, H., Gounden, V., Perritt, A. F., Kumar, P., Ling, A., Liu, C., Soldin, S. J., et al. (2018) · Clinical Endocrinology · doi:10.1111/cen.13813 · Cited by 45
Self-citationOn behalf of the Italian Society of Endocrinology, Isidori, A. M., Arnaldi, G., Boscaro, M., Falorni, A., Giordano, C. S. D. S., Giordano, R., Pivonello, R., Pozza, C., Sbardella, E., et al. (2019) · Journal of Endocrinological Investigation · doi:10.1007/s40618-019-01146-y · Cited by 44
The ATP-binding cassette proteins ABCB1 and ABCC1 as modulators of glucocorticoid action
Devine, K., Villalobos, E., Kyle, C. J., Andrew, R., Reynolds, R. M., Stimson, R. H., Nixon, M., & Walker, B. R. (2022) · Nature Reviews Endocrinology · doi:10.1038/s41574-022-00745-9 · Cited by 41
Approach to the Patient With Glucocorticoid-induced Adrenal Insufficiency
Borresen, S. W., Klose, M., Glintborg, D., Watt, T., Andersen, M., & Feldt‐Rasmussen, U. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac151 · Cited by 43
Reisch, N. (2019) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-0820-2085 · Cited by 39
A Phase 2, Multicenter Study of Nevanimibe for the Treatment of Congenital Adrenal Hyperplasia
El-Maouche, D., Merke, D. P., Vogiatzi, M. G., Chang, A. Y., Turcu, A. F., Joyal, E. G., Lin, V. H., Weintraub, L., Plaunt, M. R., Mohideen, P., et al. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa381 · Cited by 34
Self-citationIatrogenic adrenal insufficiency in adults
Martin‐Grace, J., Tomkins, M., O’Reilly, M., & Sherlock, M. (2024) · Nature Reviews Endocrinology · doi:10.1038/s41574-023-00929-x · Cited by 35
Mooij, C. F., van Herwaarden, A. E., Sweep, F. C. G. J., Roeleveld, N., de Korte, C. L., Kapusta, L., & der Grinten, H. L. C. (2017) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2017-0068 · Cited by 32
Hypoglycaemia in adrenal insufficiency
Lee, S. C., Baranowski, E. S., Sakremath, R., Saraff, V., & Mohamed, Z. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1198519 · Cited by 32
Mooij, C. F., Webb, E. A., der Grinten, H. L. C., & Krone, N. P. (2016) · Archives of Disease in Childhood · doi:10.1136/archdischild-2016-311910 · Cited by 31
The Urinary Steroidome of Treated Children With Classic 21-Hydroxylase Deficiency
Kamrath, C., Wettstaedt, L., Boettcher, C., Hartmann, M. F., & Wudy, S. A. (2017) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2016.08.006 · Cited by 30
Dry coating of solid dosage forms: an overview of processes and applications
Foppoli, A. A., Maroni, A., Cerea, M., Zema, L., & Gazzaniga, A. (2017) · Drug Development and Industrial Pharmacy · doi:10.1080/03639045.2017.1355923 · Cited by 30
Novel treatment strategies in congenital adrenal hyperplasia
Turcu, A. F., & Auchus, R. J. (2016) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000256 · Cited by 30
Factors impacting on the action of glucocorticoids in patients receiving glucocorticoid therapy
Dineen, R., Stewart, P. M., & Sherlock, M. (2019) · Clinical Endocrinology · doi:10.1111/cen.13837 · Cited by 30
Novel treatments for congenital adrenal hyperplasia
Schröder, M. A. M., & der Grinten, H. L. C. (2022) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-022-09717-w · Cited by 31
Russell, G. M., Kalafatakis, K., Durant, C. F., Marchant, N., Thakrar, J., Thirard, R., King, J., Bowles, J., Upton, T. J., Thai, N. J., et al. (2023) · Journal of Internal Medicine · doi:10.1111/joim.13721 · Cited by 28
Modified-Release Hydrocortisone: Is It Time to Change Clinical Practice?
Stewart, P. M. (2019) · Journal of the Endocrine Society · doi:10.1210/js.2019-00046 · Cited by 29
Porter, J., Withe, M., & Ross, R. J. (2018) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2018.1455496 · Cited by 26
Self-citationJohnson, T. N., & Ke, A. B. (2021) · The Journal of Clinical Pharmacology · doi:10.1002/jcph.1834 · Cited by 25
Cardiometabolic Aspects of Congenital Adrenal Hyperplasia
Krysiak, R. G., der Grinten, H. L. C., Reisch, N., Touraine, P. A., & Falhammar, H. (2024) · Endocrine Reviews · doi:10.1210/endrev/bnae026 · Cited by 25
Future Directions for Adrenal Insufficiency: Cellular Transplantation and Genetic Therapies
Graves, L. E., Torpy, D. J., Coates, P. T., Alexander, I. E., Bornstein, S. R., & Clarke, B. M. (2023) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac751 · Cited by 23
Improving glucocorticoid replacement profiles in adrenal insufficiency
Choudhury, S., Lightman, S. L., & Meeran, K. M. (2019) · Clinical Endocrinology · doi:10.1111/cen.13999 · Cited by 24
Pediatric Disorders of Sex Development
Achermann, J. C., & Hughes, I. A. (2016) · Elsevier eBooks · doi:10.1016/b978-0-323-29738-7.00023-x · Cited by 21
The management of glucocorticoid deficiency: Current and future perspectives
Dineen, R., Martin‐Grace, J., Thompson, C. J., & Sherlock, M. (2020) · Clinica Chimica Acta · doi:10.1016/j.cca.2020.03.006 · Cited by 21
Bonner, J. J., Burt, H. J., Johnson, T. N., Whitaker, M. J., Porter, J. B., & Ross, R. J. M. (2021) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2021.105913 · Cited by 21
Self-citationRecent Advances in Hydrocortisone Replacement Treatment
Mallappa, A., & Debono, M. (2015) · Endocrine development · doi:10.1159/000439329 · Cited by 20
Self-citationPetersen, K. S., Rushworth, R. L., Clifton, P. M., & Torpy, D. J. (2015) · BMC Endocrine Disorders · doi:10.1186/s12902-015-0058-6 · Cited by 20
A Contemporary Approach to the Diagnosis and Management of Adrenal Insufficiency
Charoensri, S., & Auchus, R. J. (2024) · Endocrinology and Metabolism · doi:10.3803/enm.2024.1894 · Cited by 22
Congenital Adrenal Hyperplasia
Speiser, P. (2015) · F1000Research · doi:10.12688/f1000research.6543.1 · Cited by 18
MANAGEMENT OF ENDOCRINE DISEASE: Regenerative therapies in autoimmune Addison’s disease
Gan, E. H., & Pearce, S. H. S. (2016) · European Journal of Endocrinology · doi:10.1530/eje-16-0581 · Cited by 18
Mallappa, A., Nella, A. A., Kumar, P., Brooks, K. M., Perritt, A. F., Ling, A., Liu, C.-Y., & Merke, D. P. (2017) · Journal of the Endocrine Society · doi:10.1210/js.2017-00215 · Cited by 16
Self-citationEmerging medical therapies for congenital adrenal hyperplasia
Speiser, P. (2019) · F1000Research · doi:10.12688/f1000research.17778.1 · Cited by 16
Tschaidse, L., Reisch, N., Arlt, W., de la Perrière, A. B., Hirschberg, A. L., Juul, A., Mallappa, A., Merke, D. P., Newell-Price, J. D. C., Perry, C. G., et al. (2023) · European Journal of Endocrinology · doi:10.1093/ejendo/lvac006 · Cited by 15
Self-citationArlt, W., de la Perrière, A. B., Hirschberg, A. L., Merke, D. P., Newell-Price, J. D. C., Prete, A., Rees, A., Reisch, N., Touraine, P. A., Bendfeldt, H., et al. (2025) · European Journal of Endocrinology · doi:10.1093/ejendo/lvaf130 · Cited by 16
Self-citationCurrent and future treatment options for adrenal insufficiency
Arshad, M. F., & Debono, M. (2021) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000637 · Cited by 13
Ceccato, F., Barbot, M., Lizzul, L., Selmin, E., Saller, A., Albiger, N. M. E., Betterle, C., Boscaro, M., & Scaroni, C. M. (2017) · Clinical Endocrinology · doi:10.1111/cen.13490 · Cited by 14
Classic congenital adrenal hyperplasia
Nermoen, I., Husebye, E. S., Myhre, A. G., & Løvås, K. (2017) · Tidsskrift for Den norske legeforening · doi:10.4045/tidsskr.16.0376 · Cited by 13
Graves, L. E., van Dijk, E. B., Zhu, E., Koyyalamudi, S. R., Wotton, T., Sung, D., Srinivasan, S., Ginn, S. L., & Alexander, I. E. (2024) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2024.101232 · Cited by 13
Loli, P., Menotti, S., di Filippo, L., & Giustina, A. (2025) · Endocrine · doi:10.1007/s12020-025-04341-5 · Cited by 13
Management of congenital adrenal hyperplasia: beyond conventional glucocorticoid therapy
Khattab, A., & Marshall, I. H. (2019) · Current Opinion in Pediatrics · doi:10.1097/mop.0000000000000780 · Cited by 13
A model for measuring the health burden of classic congenital adrenal hyperplasia in adults
Hummel, S., Sadler, S., Whitaker, M. J., Ara, R., Dixon, S., & Ross, R. J. M. (2016) · Clinical Endocrinology · doi:10.1111/cen.13060 · Cited by 12
Self-citationCongenital adrenal hyperplasia: New biomarkers and adult treatments
Dreves, B., Reznik, Y., & Tabarin, A. (2023) · Annales d Endocrinologie · doi:10.1016/j.ando.2023.01.008 · Cited by 11
Assessing treatment adherence is crucial to determine adequacy of mineralocorticoid therapy
Pofi, R., Bonaventura, I., Duffy, J., Maunsell, Z., Shine, B. S. F., Isidori, A. M., & Tomlinson, J. (2023) · Endocrine Connections · doi:10.1530/ec-23-0059 · Cited by 12
Extended-release Hydrocortisone Formulations—Is There a Clinically Meaningful Benefit?
Steintorsdottir, S. D., Øksnes, M., Jørgensen, A. P., & Husebye, E. S. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae822 · Cited by 11
Developing oral chronotherapy for cortisol replacement in congenital adrenal hyperplasia
Whitaker, M. J., Debono, M., & Ross, R. J. M. (2023) · Clinical Endocrinology · doi:10.1111/cen.14976 · Cited by 9
Self-citationChen, A., & Burt, M. G. (2022) · Clinical Endocrinology · doi:10.1111/cen.14850 · Cited by 11
Congenital Adrenal Hyperplasia
Mallappa, A., & Merke, D. P. (2017) · Management of Adrenal Masses in Children and Adults · doi:10.1007/978-3-319-44136-8_11 · Cited by 8
Self-citationNovel agents to treat adrenal insufficiency: findings of preclinical and early clinical trials
Peel, A., Rushworth, R. L., & Torpy, D. J. (2024) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2024.2311207 · Cited by 8
Genome editing in the adrenal gland: a novel strategy for treating congenital adrenal hyperplasia
van Dijk, E. B., Ginn, S. L., Alexander, I. E., & Graves, L. E. (2024) · Exploration of Endocrine and Metabolic Diseases · doi:10.37349/eemd.2024.00011 · Cited by 8
Prete, A., Theiler‐Schwetz, V., Arlt, W., Hazeldine, J., Chifu, I.-O., Harbeck, B., Napier, C., Newell-Price, J. D. C., Rees, D. A., Reisch, N., et al. (2026) · EClinicalMedicine · doi:10.1016/j.eclinm.2025.103714 · Cited by 9
Self-citationRees, A., Merke, D. P., Arlt, W., de la Perrière, A. B., Hirschberg, A. L., Juul, A., Newell-Price, J. D. C., Prete, A., Reisch, N., Stikkelbroeck, N. M. M. L., et al. (2024) · Endocrine Connections · doi:10.1530/ec-24-0150 · Cited by 9
Self-citationNouveautés dans l’hyperplasie congénitale des surrénales
Dumeige, L., Bouvattier, C. M., & Lombès, M. (2017) · Annales d Endocrinologie · doi:10.1016/s0003-4266(17)30922-8 · Cited by 7
Auchus, R. J., Courtillot, C., Dobs, A. S., El‐Maouche, D., Falhammar, H., Lacroix, A., Farrar, M., O’Donoghue, C., Anatchkova, M., Cutts, K. N., et al. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1005963 · Cited by 7
Health problems of adolescent and adult patients with 21-hydroxylase deficiency
Tajima, T. (2018) · Clinical Pediatric Endocrinology · doi:10.1297/cpe.27.203 · Cited by 7
Congenital adrenal hyperplasia
Krone, N. P., & Hughes, I. A. (2020) · doi:10.1093/med/9780198746690.003.0250 · Cited by 7
Neumann, U., Blankenstein, O., & der Grinten, H. L. C. (2025) · Endocrine Connections · doi:10.1530/ec-24-0619 · Cited by 6
Ng, S. M., & Stępień, K. M. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012517 · Cited by 6
Flokas, M. E., Yang, L., Middleton, K. R., Kollender, S., Parker, M., Sukin, C., Persky, R., & Merke, D. P. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae309 · Cited by 6
Self-citationQuality of Life in Patients with Adrenal Insufficiency
Li, D. (2022) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2022.04.003 · Cited by 5
Metadata
- Authors
- Mallappa, A., Sinaii, N., Kumar, P., Whitaker, M. J., Daley, L.-A., Digweed, D., Eckland, D. J. A., Van Ryzin, C., Nieman, L. K., Arlt, W., Ross, R. J., & Merke, D. P.
- Affiliations
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (US)
- National Institutes of Health (US)
- Diurnal (United Kingdom) (GB)
- Corresponding author
- Mallappa, Ashwini
- Ross, Richard J.
- ORCID
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2015-03
- Volume
- 100
- Issue
- 3
- Pages
- 1137-1145
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- PMC
- PMC5393506
- OpenAlex
- W1976145935
- Cited by
- 167
- References
- 36
- Citations by year
- 2026: 11 · 2025: 16 · 2024: 17 · 2023: 11 · 2022: 16 · 2021: 10 · 2020: 11 · 2019: 16 · 2018: 18 · 2017: 17 · 2016: 19 · 2015: 5
- FWCI
- 5.61
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- University of Birmingham Research Portal (University of Birmingham) (submittedVersion, other-oa)
- Spiral (Imperial College London) (submittedVersion)
- Funders
- National Institutes of Health
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Sexual Differentiation and Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
- Keywords
- congenital adrenal hyperplasia, cortisol, modified-release formulation, diurnal cortisol rhythm, androstenedione, 17-hydroxyprogesterone, hyperandrogenism, treatment tolerability
- MeSH terms
- Adolescent, Adrenal Hyperplasia, Congenital, Adult, Capsules, Circadian Rhythm, Delayed-Action Preparations, Drug Administration Schedule, Female, Humans, Hydrocortisone, Male, Middle Aged, Quality of Life, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
